| Aug 7 |
Zai Lab Limited (ZLAB) Q2 2024 Earnings Call Transcript
|
| Aug 6 |
Zai Lab ADR of -$0.82 misses by $0.12, revenue of $100.5M beats by $7.36M
|
| Aug 6 |
Zai Lab Announces Second Quarter 2024 Financial Results and Recent Corporate Updates
|
| Jul 17 |
China NMPA approves Zai Lab-argenx’s efgartigimod alfa for gMG
|
| Jul 16 |
Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
|
| Jul 15 |
Zai Lab-Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers, Including Through Combination PARP Inhibitor and CCR8 Therapy
|
| Jul 10 |
Best Momentum Stocks to Buy for July 10th
|
| Jul 10 |
Zai Lab to Announce Second Quarter 2024 Financial Results and Recent Corporate Updates on August 6, 2024
|
| Jun 13 |
Increases to CEO Compensation Might Be Put On Hold For Now at Zai Lab Limited (NASDAQ:ZLAB)
|
| Jun 11 |
Zai Lab Announces Dr. Harald Reinhart to Retire as Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases; Dr. Rafael Amado to be Appointed President, Head of Global R&D
|
